Francoise Valensi
Overview
Explore the profile of Francoise Valensi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
612
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mahlaoui N, Minard-Colin V, Picard C, Bolze A, Ku C, Tournilhac O, et al.
J Pediatr
. 2010 Sep;
158(1):142-8, 148.e1.
PMID: 20846672
Objective: To better describe the natural history, mode of inheritance, and the epidemiological and clinical features of isolated congenital asplenia, a rare and poorly understood primary immunodeficiency. Study Design: A...
2.
Lagresle-Peyrou C, Six E, Picard C, Rieux-Laucat F, Michel V, Ditadi A, et al.
Nat Genet
. 2008 Dec;
41(1):106-11.
PMID: 19043416
Reticular dysgenesis is an autosomal recessive form of human severe combined immunodeficiency characterized by an early differentiation arrest in the myeloid lineage and impaired lymphoid maturation. In addition, affected newborns...
3.
Lacoste V, Nicot C, Gessain A, Valensi F, Gabarre J, Matta H, et al.
Br J Haematol
. 2007 Jul;
138(4):487-501.
PMID: 17659053
Primary effusion lymphoma (PEL) is a rare, distinct subtype of non-Hodgkin lymphoma, which is associated with Kaposi sarcoma-associated herpesvirus (KSHV) infection. Although MYB levels are high in most neoplastic B...
4.
Letestu R, Marzac C, Audat F, Belhocine R, Tondeur S, Baccini V, et al.
Leuk Lymphoma
. 2007 Mar;
48(1):89-96.
PMID: 17327950
Successful peripheral blood stem cell (PBSC) collection depends on the timing of apheresis based on CD34+ cell enumeration. Because this analysis is expensive and induces organization difficulties, we evaluated hematopoietic...
5.
Ugo V, Leporrier N, Salaun V, Letestu R, Radford-Weiss I, Ramond S, et al.
Leuk Lymphoma
. 2006 Oct;
47(10):2088-95.
PMID: 17071481
Diagnosis of leukemic B-cell chronic lymphoproliferative disorders (B-CLPD) is a frequent challenge in hematology. In this multicentric study, we prospectively studied 165 new consecutive leukemic patients with B-CLPD selected on...
6.
Thaunat O, Mamzer-Bruneel M, Agbalika F, Valensi F, Venditto M, Lebbe C, et al.
Blood
. 2006 Mar;
107(7):3009-10.
PMID: 16554487
No abstract available.
7.
Tourneur L, Delluc S, Levy V, Valensi F, Radford-Weiss I, Legrand O, et al.
Cancer Res
. 2004 Nov;
64(21):8101-8.
PMID: 15520222
In acute myeloid leukemia (AML), coexpression of death receptors and ligands of the tumor necrosis factor (TNF) receptor/TNF-alpha superfamily on leukemic cells after chemotherapy is not always accompanied by apoptosis,...
8.
Saadoun D, Suarez F, Lefrere F, Valensi F, Mariette X, Aouba A, et al.
Blood
. 2004 Sep;
105(1):74-6.
PMID: 15353484
Hepatitis C virus (HCV) has been associated with the development of B-cell non-Hodgkin lymphomas. We recently reported the regression of splenic lymphoma with villous lymphocytes (SLVL) in patients with HCV...
9.
Aouba A, Lambotte O, Vasiliu V, Divine M, Valensi F, Varet B, et al.
Am J Hematol
. 2004 May;
76(2):187-9.
PMID: 15164389
A 55-year-old Caribbean woman with a 6-year history of smoldering adult T-cell leukemia/lymphoma presented with clinical and biological symptoms of hemophagocytic syndrome. An extensive search for infectious diseases was negative....
10.
Jacob M, Chaperot L, Mossuz P, Feuillard J, Valensi F, Leroux D, et al.
Haematologica
. 2003 Aug;
88(8):941-55.
PMID: 12935983
Background And Objectives: The CD4+ CD56+ lin- immunophenotype characterizes rare malignancies, so far considered as arising from the transformation of NK progenitors, and therefore classified as blastic NK-cell leukemia/lymphoma by...